<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article article-type="correction" dtd-version="2.3" xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Cell Dev. Biol.</journal-id>
<journal-title>Frontiers in Cell and Developmental Biology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Cell Dev. Biol.</abbrev-journal-title>
<issn pub-type="epub">2296-634X</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">1655115</article-id>
<article-id pub-id-type="doi">10.3389/fcell.2025.1655115</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Cell and Developmental Biology</subject>
<subj-group>
<subject>Correction</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Correction: Optimizing Nodal, Wnt and BMP signaling pathways for robust and efficient differentiation of human induced pluripotent stem cells to intermediate mesoderm cells</article-title>
<alt-title alt-title-type="left-running-head">Magro-Lopez et al.</alt-title>
<alt-title alt-title-type="right-running-head">
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fcell.2025.1655115">10.3389/fcell.2025.1655115</ext-link>
</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Magro-Lopez</surname>
<given-names>Esmeralda</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2739610/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Vazquez-Alejo</surname>
<given-names>Elena</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1708711/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Espinar-Buitrago</surname>
<given-names>Mar&#xed;a de la Sierra</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2739631/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Mu&#xf1;oz-Fern&#xe1;ndez</surname>
<given-names>Mar&#xed;a &#xc1;ngeles</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<uri xlink:href="https://loop.frontiersin.org/people/548431/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>Molecular Immuno-Biology Laboratory, Immunology Section</institution>, <institution>Hospital General Universitario Gregorio Mara&#xf1;&#xf3;n (HGUGM)</institution>, <addr-line>Madrid</addr-line>, <country>Spain</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>Instituto de Investigaci&#xf3;n Sanitaria Gregorio Mara&#xf1;&#xf3;n (IiSGM)</institution>, <addr-line>Madrid</addr-line>, <country>Spain</country>
</aff>
<aff id="aff3">
<sup>3</sup>
<institution>Biomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN)</institution>, <institution>Instituto de Salud Carlos III (ISCIII)</institution>, <addr-line>Madrid</addr-line>, <country>Spain</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>
<bold>Approved by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/56085/overview">Frontiers Editorial Office</ext-link>, Frontiers Media SA, Switzerland</p>
</fn>
<corresp id="c001">&#x2a;Correspondence: Mar&#xed;a &#xc1;ngeles Mu&#xf1;oz-Fern&#xe1;ndez, <email>mmunoz.hgugm@gmail.com</email>
</corresp>
</author-notes>
<pub-date pub-type="epub">
<day>11</day>
<month>07</month>
<year>2025</year>
</pub-date>
<pub-date pub-type="collection">
<year>2025</year>
</pub-date>
<volume>13</volume>
<elocation-id>1655115</elocation-id>
<history>
<date date-type="received">
<day>27</day>
<month>06</month>
<year>2025</year>
</date>
<date date-type="accepted">
<day>30</day>
<month>06</month>
<year>2025</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2025 Magro-Lopez, Vazquez-Alejo, Espinar-Buitrago and Mu&#xf1;oz-Fern&#xe1;ndez.</copyright-statement>
<copyright-year>2025</copyright-year>
<copyright-holder>Magro-Lopez, Vazquez-Alejo, Espinar-Buitrago and Mu&#xf1;oz-Fern&#xe1;ndez</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<related-article id="RA1" related-article-type="corrected-article" journal-id="Front. Cell Dev. Biol." journal-id-type="nlm-ta" xlink:href="10.3389/fcell.2024.1395723" ext-link-type="doi">A Correction on: <article-title>Optimizing Nodal, Wnt and BMP signaling pathways for robust and efficient differentiation of human induced pluripotent stem cells to intermediate mesoderm cells</article-title> by Magro-Lopez E, Vazquez-Alejo E, Espinar-Buitrago MdlS and Mu&#xf1;oz-Fern&#xe1;ndez M&#xc1; (2024). <italic>Front. Cell Dev. Biol.</italic> 12:1395723. doi: <object-id>10.3389/fcell.2024.1395723</object-id>
</related-article>
<kwd-group>
<kwd>hiPSC</kwd>
<kwd>mesoderm progenitors</kwd>
<kwd>intermediate mesoderm</kwd>
<kwd>Nodal</kwd>
<kwd>Wnt</kwd>
<kwd>BMPs</kwd>
<kwd>3D organoids</kwd>
<kwd>urogenital organoids</kwd>
</kwd-group>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-at-acceptance</meta-name>
<meta-value>Stem Cell Research</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<p>In the published article, there was an omission in the Funding statement.</p>
<p>The co-funders Ministerio de Ciencia e Innovaci&#xf3;n and Uni&#xf3;n Europea&#x2013;European Regional Development Fund were erroneously omitted.</p>
</body>
<back>
<sec sec-type="funding-information" id="s1">
<title>Funding</title>
<p>The author(s) declare that financial support was received for the research and/or publication of this article. This work has been supported with resources from ISCIII (grant number PI23/01137) and co-funded by the European Union, and by CIBER -Consorcio Centro de Investigaci&#xf3;n Biom&#xe9;dica en Red- (CIBER-BBN) (CB22/01/00041), Instituto de Salud Carlos III, Ministerio de Ciencia e Innovaci&#xf3;n and Uni&#xf3;n Europea &#x2013; European Regional Development Fund. EM-L was supported by the Instituto de Investigaci&#xf3;n Sanitaria Gregorio Mara&#xf1;&#xf3;n under grant agreement &#x201c;2022-II-POSTDOC-01&#x201d; through the Intramural Program.&#x201d; EV-A was supported by CIBER -BBN, ISCIII (CB22/01/00041), Instituto de Salud Carlos III, Ministerio de Ciencia e Innovaci&#xf3;n and Uni&#xf3;n Europea &#x2013; European Regional Development Fund. MSE-B was supported with resources from ISCIII (grant number PI19/01638) and co-funded by the European Union.</p>
<p>The original article has been updated.</p>
</sec>
<sec sec-type="disclaimer" id="s2">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
</back>
</article>